BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

MBio Diagnostics, Inc. Will Present at Biotech Showcase in San Francisco, Monday January 7, 2013


1/4/2013 8:56:59 AM

BOULDER, CO--(Marketwire - January 03, 2013) -

MBio Diagnostics, Inc., a diagnostics company focused on enabling better healthcare decisions through immediate multi-disease diagnostics, today announced that Michael J. Lochhead, Ph.D., Vice President of MBio Diagnostics, will present a company overview at the Biotech Showcase, on Monday, January 7 at 2:30 p.m. PST at the Parc 55 Hotel in San Francisco, CA. The presentation will focus on MBio's near-term plans to commercialize the first in a pipeline of diagnostic products on a single platform developed to deliver comprehensive testing of multiple diseases from a single sample.

About MBio:

MBio Diagnostics, Inc. (www.mbiodx.com) is a privately held clinical diagnostics and life sciences technology company based in Boulder, CO. MBio is developing a suite of simple, multiplexed diagnostic tests using its proprietary LightDeck™ technology. Initial product development focuses on high impact infectious diseases, including HIV, hepatitis, and influenza. The company's product development is aimed at decentralized testing, from the clinic to the home.


For more information visit MBio at www.mbiodx.com or contact:

Michael Seely
MBio Diagnostics, Inc.
Phone: 303-952-2830
Fax: 303-951-1529
E-mail: Email Contact


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->